While it doesn't directly predict sweating, it reveals your genetic thermoregulatory and metabolic profile, helping your provider anticipate your response and personalize your therapy from the start
Losing weight already increases the risk of gallstones, and GLP-1s seem to increase it even further
But not every researcher follows the standard
Your anonymised results will be added to the COGNITION Biobank, helping advance our understanding of the links between nutrition, lifestyle and cognitive health
Semaglutide does slow gastric emptying, which is one of the ways it reduces appetite, and in theory that could change how a tablet like levothyroxine is absorbed
Retatrutide Retatrutide is a novel weight loss treatment, manufactured by Eli Lilly, to treat obesity and type 2 diabetes